ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease
- 1 August 2006
- journal article
- Published by Elsevier in Kidney International
- Vol. 70 (4), 781-787
- https://doi.org/10.1038/sj.ki.5001632
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The Determinants of Endothelial Dysfunction in CKD: Oxidative Stress and Asymmetric DimethylarginineAmerican Journal of Kidney Diseases, 2006
- Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction—The Hoorn StudyKidney International, 2004
- Low dialysance of asymmetric dimethylarginine (ADMA) - in vivo and in vitro evidence of significant protein bindingClinical Nephrology, 2004
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Hypercholesterolemia impairs basal nitric oxide synthase turnover rate: a study investigating the conversion of l-[guanidino-15N2]-arginine to 15N-labeled nitrate by gas chromatography–mass spectrometryNitric Oxide, 2004
- Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertensionAmerican Heart Journal, 2004
- Endothelial dysfunction and inflammation in asymptomatic proteinuriaKidney International, 2003
- Microalbuminuria, Cardiovascular, and Renal Risk in Primary HypertensionJournal of the American Society of Nephrology, 2002
- Vascular function of the peripheral circulation in patients with nephrosisKidney International, 2001
- Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis StudyKidney International, 2000